eview of absorbed dose calculation methods...
TRANSCRIPT
REVIEW OF ABSORBED DOSE CALCULATION METHODS: IMPLICATIONS FOR FUTURE CLINICAL IMPLEMENTATION
Alex Vergara Gil: [email protected] / Manuel Bardiès: [email protected]
CONCEPTS
I. BASIC DOSIMETRY a) ABSORBED DOSE IS DEPOSITED ENERGY IN A MASS ELEMENT!b) CONDITIONS:
1. A RADIATION SOURCE VOLUME SOMEWHERE
2. A TARGET VOLUME SOMEWHERE
3. THE INTENSITY AND CHARACTERISTICS OF THE RADIATION WILL BE CHANGED ON ITS WAY TOWARD THE TARGET VOLUME!
III. EQUATION USED IN SOME SPECIFIC REGION BASED METHODS (2)
a) A0 IS THE INJECTED ACTIVITY
b) EDEP DESCRIBES THE ENERGY RATE ABSORBED IN THE TARGET R PER UNIT DISINTEGRATION
c) M IS THE MASS OF THE TARGET REGION R IN TIME
d) THE INTEGRATION IS PERFORMED USING PHARMACOKINETICS IN THE TARGET REGION R
II. COMMON EQUATION FOR DOSIMETRY IN NUCLEAR MEDICINE (1)
a) Ã IS THE TOTAL NUMBER OF DISINTEGRATIONS (CUMULATED ACTIVITY) IN THE SOURCE H
b) S DESCRIBES THE ENERGY, EMITTED FROM THE SOURCE H, ABSORBED IN THE TARGET K PER MASS UNIT AND
DISINTEGRATION.
CLINICAL DOSIMETRY
• Multiple steps procedure
• Not just calculation
• Codes/software may address ≠ parts
CLINICAL DOSIMETRY
• Absorbed dose: calculated for a purpose
• Disease/Radiopharmaceutical/Isotope specific
• Not a UNIQUE solution
• There may be different codes for different use…
CLINICAL DOSIMETRY
• Academic software– Developped by research groups
– Opensource?
– Availability (±…)
– Research: not for clinical use...
• Vendor software– Meant for the clinics
– Aim for FDA/EMA approval
ABSORBED DOSE CALCULATION
Monte-Carlo
Convolution
Local energy
deposition
Speed
Accu
racy
S FactorsPatient Specific
ABSORBED DOSE CALCULATION
Monte-Carlo
Convolution
Local energy
deposition
Speed
Accu
racy
S FactorsPatient Specific
days
hours
minutes
minutes
Year 2000
ABSORBED DOSE CALCULATION
Monte-Carlo
Convolution
Local energy
deposition
Speed
Accu
racy
S FactorsPatient Specific
hours (typically 1-4)
minutes
seconds
seconds
Question: Is Monte Carlo the Holy Grail?
Answer: No
Today, year 2018
ABSORBED DOSE CALCULATION
Monte-Carlo
Convolution
Local energy
deposition
Speed
Accu
racy
S FactorsPatient Specific
• Accuracy is patient specific, isotope specific and region specific
• Monte Carlo is not applicable in all cases
MEDIRAD
IMPLICATIONS OF MEDICAL LOW DOSE RADIATION EXPOSURE
DELIVERABLE 3.3DOSIMETRY PROTOCOL AND SOFTWARE
LEAD PARTNER:
Workflow Diagrams defining protocol approaches made by:Manuel Bardies, Bernard Guibaud, Marine Brennet, Alex Vergara Gil, Juan Camilo Ocampo Ramos,Erick Mora Ramirez
PANDORA Project
2D DOSIMETRY
• SET OF PLANAR IMAGES (CAN BE WB) IS ACQUIRED AT DIFFERENT TIME POINTS
• REGION BASED QUANTIFICATION
• USE OF TABULAR DATA FOR REFERENCE MODELS IS USED TO CONVERT MEASURED ACTIVITY INTO DOSE
2D DOSIMETRY
Acquisition and processing workflowDetermination of A
Dosimetry workflow:Determination of SIntegration in timeRadiobiology
2D DOSIMETRY
• WORKFLOW : DOSIMETRY
Time Activity Curve Fit(Pharmaco.K Assessment)
Radio-Biological Calculation
Biological Effective Dose
Radio-biologicalcalculation method
Mean Absorbed Dose Rate (ROI1, 2,…., n-1, n)
Net administeredActivity
Time integrated activityper ROI(cumulated activity) 1,
2,…., n-1, n
Time integrated activitycoefficients per ROI(residence time)1, 2,…., n-1, n
Mean Absorbed Dose (ROI1, 2,…., n-1, n)
Organ S-value
Patient organmass (Opt)
Time Absorbed Dose Curve Fit(Pharmaco.K Assessment)
Data Activity per ROI
Absorbed Dose Calculation
Model-based absorbed dose calculation
Adjusted model-based absorbed dose calculation
(if patient organ mass)
Data Activity per ROI
Patient organ mass(ROI1, 2,…., n-1, n) (Opt)
Absorbed Dose (1 value)(ROI1, 2,…., n-1, n)
TimePoint1, 2,…., n-1, n
Absorbed Dose Rate Calculation
• Model-based absorbed dose rate
calculation
• Adjusted model-based absorbed dose
rate calculation
PK assessmentmethod
Radio-biologicalcalculation parameters
PK assessmentmethod
Net administeredActivity
ABSORBED DOSE CALCULATION
ASIDE OF ABSORBED DOSE CALCULATION
• We need to consider that Absorbed Dose calculation is not isolated process in the workflow
– Is deeply inserted in the whole workflow
– The procedure depends on the techniques used to acquire the images
– The accuracy depends on the techniques used to process the images
– The result of this calculations are not the goal of dosimetric workflow, these are just intermediate step
BEYOND ABSORBED DOSE
• RADIOBIOLOGY CONSIDERATIONS
EUD / TCP
• Prideaux et al. ”Three-Dimensional Radiobiologic Dosimetry: …“. J Nucl Med 2007; 48:1008–1016.
• Wessels et al. “MIRD Pamphlet No. 20: …”, J Nucl Med 2008; 49:1884–1899
• Sgouros et al. “Three-Dimensional Imaging-Based Radiobiological Dosimetry”. Semin Nucl Med 2008; 38:321-334.
ABSORBED DOSE CALCULATION
Monte-Carlo
Convolution
Local energy
deposition
Speed
Accu
racy
S FactorsPatient Specific
LOCAL ENERGY DEPOSITION
• The degree zero of dosimetry…• However… If activity is known with a
spatial sampling > radiation range...• What is the point in
propagating radiation?• OK for alpha, beta? (microdosimetry)• Not OK for gamma, X. BUT most often a
very minor component of absorbed dose delivered to a given organ...
Some dosimetry software uses a hybrid method of LED for alpha, beta and Monte Carlo for photons using the best of both methods
The energy emitted by the particle is totally absorbed in the point of origin.
S FACTOR CALCULATION
MIRDOSE3
OlindaRefined analytical phantoms
Voxelized phantoms
S FACTOR CALCULATION
Voxel
Stylized
Hybrid
1950 1960 1970 1980 1990 2000 2010
ICRU
sphere
1950’s
MIRD/ORNL
1980’s
ICRP/ICRU
2009
Hybrid
Hybrid phantoms are stylized derived from voxelized
S FACTOR CALCULATION
Divoli et al. (2009) JNM 50(2):316-323
Using Monte Carlo
S FACTOR CALCULATION
Phantoms
Dosimetric
Models
OLINDA/MIRDO
SE3
KERNEL CONVOLUTION
Giap et al. Phys Med Biol. 1995, Mar;40(3):365-81
Monte Carlo
KERNEL CONVOLUTION
Giap et al. Phys Med Biol. 1995, Mar;40(3):365-81
Monte Carlo
3-D Map of Cumulated Activity
Concentration
Absorbed DoseD(r)
KERNEL CONVOLUTION
Monte Carlo
Deposited Energypoint kernel
E(f,t)=A(f,t).k(f)
Targetorgan/voxel mass
KERNEL CONVOLUTION
VOXEL CONVOLUTION
HCC treated with 90Y microspheres
Courtesy: A Dieudonné (VoxelDose)
Pre-calculated voxel S-Factors
MONTE CARLO
ADVANTAGES
Non homogeneous Tissues
FUNTIONAL IMAGE
ANATOMIC IMAGE
INTE
RFA
CE
MC SIMULATION3D Absorbed Dose
Distributions
DVHIsodose Curves
Mean, Max Values
(MCNPx, EGSnrc, GEANT4, GATE, etc)
VOI Analysis
Tables of Absorbed Dose per VOI
MONTE CARLO
VOXEL VS. REGION APPROACHES
Why voxels are not necessarily the best option...
Peter et al. 2000 IEEE transactions on medical imaging, 19(5), pp. 556-64
MULTISCALE DOSIMETRY
Marcatili et al. PMB 2014
3D DOSIMETRY – VOXEL BASED
3D DOSIMETRY – VOXEL BASED
• THERE WERE NO SIGNIFICANT DIFFERENCES IN THE KIDNEY VOLUMES BETWEEN CYCLES. HOWEVER, THE KIDNEY VOLUMES
THAT WERE MEASURED AT THE FIRST AND THE FOURTH TREATMENTS LAY WITHIN 10% OF EACH OTHER FOR ONLY 12 OF
24 PATIENTS (50%). ONE PATIENT HAD AN INCREASE IN SIZE OF MORE THAN 20% IN THE RIGHT SIDE KIDNEY AND
ANOTHER PATIENT HAD A SIMILAR INCREASE ON THE LEFT SIDE. ONE PATIENT HAD A LEFT-SIDED DECREASE BY MORE THAN
20%.
3D DOSIMETRY – VOXEL BASED
Real problematic with registration based approaches
T0: Diagnostic CT, full stomach, liverand spleen displaced
T1: Low Dose CT, empty stomach, liver and spleen displaced
The lesion is also displaced and the shape has changed!!
Image courtesy of: Institute of Cancer of Montpellier
3D DOSIMETRY
I. MAIN ISSUE WITH 3D DOSIMETRY – SEGMENTATION
a) DEPENDENT OF THE TECHNICIAN, USUALLY NEEDS CLINICIAN VALIDATION
b) TAKES LOADS OF TIME, ACTUALLY MORE THAN MC SIMULATION ITSELF!c) USED EVERYWHERE, TO DEFINE THE MEDIAS FOR SIMULATION, TO DEFINE THE MASS AND ACTIVITY, TO
DEFINE THE REGIONS FOR PK INTEGRATION IN TIME
MULTISCALE DOSIMETRY
Marcatili et al. PMB 2014
CLINICAL DOSIMETRY
• Academic software– Developped by research groups
– Opensource?
– Availability (±…)
– Research: not for clinical use...
• Vendor software– Meant for the clinics
– Aim for FDA/EMA approval
CONVOLUTION
RMDP (M Guy, RMH) NukDos (M Laßmann, UKW)
MONTE CARLO
Kolbert KS, Sgouros G, Scott AM, et al. J Nucl Med. 1997;38:301–308.
• Osem Reconstruction (OSEM)
• Image Processin (MIAU)
• Image Corregistration
• Dose Claculation by Monte
Carlo techniques and the
kernel methods.
• Curve fitting at voxel level.
• Radiobiology analysis of data
3D-ID. Implementation and evaluation of patient-specific three-dimensional internal dosimetry. (Memorial Sloan-Kettering Cancer Center, NY, USA)
(3D-ID / 3D-RD)
MONTE CARLO
131I
d0, d1, d3, ...
MCNPX
S Chiavassa et al. (2006) PMB 51:601-616
MONTE CARLO
S Chiavassa et al. (2006) PMB 51:601-616
Application : LipioCis™
• 194 x 140 x 90 voxels
• (2.21 x 2.21 x 4.42 mm3)
• Organ : 45 min (σ<2%)
• Voxel : 3.8 d (σ<10%)
MONTE CARLO
CANCER BIOTHERAPY & RADIOPHARMACEUTICALS Volume 20, Number 1, 2005
The LundADose Method for Planar Image Activity Quantification and Absorbed-Dose assessment in RNT (Lund University. Sweden)
DOSIMG
MONTE CARLO
CANCER BIOTHERAPY & RADIOPHARMACEUTICALS Volume 30, Number 1, 2015
MONTE CARLO
Courtesy: E Spezi (Velindre, Cardiff)Marcatili et al. Phys Med Biol 2013 58 2491-2508
CLINICAL DOSIMETRY
• Academic software– Developped by research groups
– Opensource?
– Availability (±…)
– Research: not for clinical use...
• Vendor software– Meant for the clinics
– Aim for FDA/EMA approval
EXAMPLE OF COMMERCIAL WORKSTATIONS
ReportRT-Dose
Comparison
99Tcm-MAAdosimetry 90Y-microspheresdosimetry
Invivocontrol
TherapyresponseRECIST1.1,PERCIST1.0
Post-treatmentexams
Follow-up
Pre-treatmentexams
Review,segmentation,quantification
Diagnosis
Multi-modalimageregistration
Post-implantationdosecalculation
90Y-microspheresPET/CTexam
TreatmentPlanning
Segmentationand/orstructureimport
Pre-implantationdosecalculation
99Tcm-MAASPECT/CTexam
RT-Struct
Processing workflow
EXAMPLE OF COMMERCIAL WORKSTATIONS
• Vendor Software (DosiSoft)
• Treatment planning system for SIRT & now systemic therapy dosimetry
• CE marking! Clinical solution
• Absorbed dose calculation: LED & Convolution
• Dose Volume Histograms
EXAMPLE OF COMMERCIAL WORKSTATIONS
HERMES Dosimetry Software Current overview and future directions
April 2015
[email protected] HERMES Dosimetry Software Current overview and future directions
April 2015
Important player in Nuclear Medicine“Nuclear Diagnostics”Multimodality workstationManufacturer independent…Research Tool: FDA approval pendant
EXAMPLE OF COMMERCIAL WORKSTATIONS
HERMES Dosimetry Software Current overview and future directions
April 2015
Hybrid ViewerTM Dosimetry [MIRD Calculation]
Can be used with the following combinations of data - Multiple Planar - Multiple Planar + one SPECT-CT - Multiple SPECT-CT or PET-CT
MIRD Phantom
Voxel Based
SPECT Recon
Introduction
SIRT Microspheres
EXAMPLE OF COMMERCIAL WORKSTATIONS
HERMES Dosimetry Software Current overview and future directions
April 2015
• Historically 3D voxel-based dosimetry is time-consuming
• HERMES has developed Hybrid 3Dose-package, which combines the following dosimetry steps in a clinically valid time:
1. Reconstruction 2. Registration 3. Curve-fitting 4. MC-based dose calculation 5. Semiautomatic ROI drawing of organs from CT 6. Automatic lesion detection 7. Reporting
Hybrid 3Dose – Monte Carlo
Voxel Based
MIRD Phantom
SPECT Recon
Introduction
SIRT Microspheres
EXAMPLE OF COMMERCIAL WORKSTATIONS
EXAMPLE OF COMMERCIAL WORKSTATIONS
STRATOS
• Vendor Software (Philips)
• From clinical images to absorbed dose– Essentially 3D!
• Computation: kernel convolution (no mass adjustment)– Dose Volume Histograms
• Research Tool: NO FDA/EMA/CE approval
EXAMPLE OF COMMERCIAL WORKSTATIONS
EXAMPLE OF COMMERCIAL WORKSTATIONS
DOSIMETRIX
• Vendor Software (GE)
• From clinical images to Residence time– Essentially 3D!
• NO Absorbed dose calculation!– Uses MIRD S Factors (Future?)
• Clinical Tool: FDA/EMA/CE approval
COMMERCIAL WORKSTATIONS AVAILABLE AT CRCT
COMMERCIAL WORKSTATIONS AVAILABLE AT CRCT
PDOSE STRATOS
STRATOS is part of the IMALYTICS
Research workstation (Imalytics3.2, Rev 6289(64)) by Phillips,and operates on Windows. Itallows the user to perform 3Ddosimetry from multiple SPECT/CTscans. Registration (MN-1CT) andsegmentation can be done in theMN & CT matrices. It can generateTAC’s and performs fitting byusing the trapezoid method. Itperforms voxel-based dosimetry(convolution). It can be used for18F, 68Ga, 124I, 131I, 111In, 177Lu,99mTc, 90Y, 188Re, 166Ho,153Sm.
Hybrid Viewer DosimetryModule™ (HVD), version 1.0 byHERMES works on Windows. It hasFDA approval. It can be used withat least 3 SPECT/CT scans or 3whole body scans (WB’s) and oneSPECT/CT or 3 WB’s.Reconstruction can be done aswell as registration, segmentation(MN&CT). It can generate TAC’sand performs mono-exponential(3 scans) and bi-exponential (4scans minimum) fittings.Residence time results areexported to OLINDA/EXM V2.0. Itcan be used for 11C, 18F, 67Ga, 68Ga,123I, 131I, 111In, 177Lu, 13N, 15O, 82Rb,99mTc, 201Tl, 90Y, 188Re, 166Ho, 81Kr.
PLANET® Onco Dose (PDOSE) ,Edition 3, version 3.0 was createdby Dosisoft, operating on Linux(7.3.1611, CentOS7 -64bits).PDOSE for Selective InternalRadiotherapy (SIRT 90Y) has FDAapproval. PDOSE can also be usedfor Nuclear Medicine systemictherapy (177Lu). It allows the userto perform full 3D dosimetry fromreconstructed images.Registration of multiple SPECT/CTscans segmentation can be donein the MN & CT matrices. It cangenerate TAC’s and it has multiplefitting options. Now performorgan-based and voxel-baseddosimetry.
COMMERCIAL WORKSTATIONS AVAILABLE AT CRCTActivity estimation
Activity estimation for OSEM (6i, 10ss) + AC + RR + SC + Non GPF
Day Time
Activity (MBq) % Relative difference in
activity
FittingMono-ExponentialResidence time (h)
% Relative difference in
Residence timeSoftware
Theoric Estimation
27/04/16 19:28 529.80 550.62 -3,9
241.93 4.439 HVDM
28/04/16 17:56 480.53 499.73 -4,0
29/04/16 18:01 432.78 463.17 -7,0
03/05/16 19:15 283.66 297.51 -4,9
04/05/16 17:40 257.33 267.11 -3,8
27/04/16 19:28 529.80 546.72 3,2
222.00 -3.543 PLANET
28/04/16 17:56 480.53 480.75 0,04
29/04/16 18:01 432.78 432.86 0,01
03/05/16 19:15 283.66 283.18 -0,17
04/05/16 17:40 257.33 251.72 -2,2
27/04/16 19:28 529.80 560.00 5.7
114.00 -50.52
STRATOS*(fitting
trapezoidal method)
28/04/16 17:56 480.53 390.00 -18.8
29/04/16 18:01 432.78 350.00 -19.1
03/05/16 19:15 283.66 110.00 -61.2
04/05/16 17:40 257.33 100.00 -61.1
FINAL REMARKS
• No unique solution for dosimetry.– Different modalities = different approaches
• No available solution yet for mass variation with time, for correction of registration process and for accurate automatic segmentation.
MERCI DE VOTRE ATTENTION
THANKS FOR YOUR ATTENTION
Centre de Recherches en Cancérologie de Toulouse
www.crct-inserm.fr
NUCLEAR MEDICINE QC PLUGINS
NUCLEAR MEDICINE E-LEARNING
http://www-
naweb.iaea.org/elearning/NMDI/Quality_Assurance_for_SPECT_Systems/story.html
16 tutorial videos
16 tutorial videos